Literature DB >> 15181027

Medical consequences of obesity.

George A Bray1.   

Abstract

Obesity is an epidemic disease that threatens to inundate health care resources by increasing the incidence of diabetes, heart disease, hypertension, and cancer. These effects of obesity result from two factors: the increased mass of adipose tissue and the increased secretion of pathogenetic products from enlarged fat cells. This concept of the pathogenesis of obesity as a disease allows an easy division of disadvantages of obesity into those produced by the mass of fat and those produced by the metabolic effects of fat cells. In the former category are the social disabilities resulting from the stigma associated with obesity, sleep apnea that results in part from increased parapharyngeal fat deposits, and osteoarthritis resulting from the wear and tear on joints from carrying an increased mass of fat. The second category includes the metabolic factors associated with distant effects of products released from enlarged fat cells. The insulin-resistant state that is so common in obesity probably reflects the effects of increased release of fatty acids from fat cells that are then stored in the liver or muscle. When the secretory capacity of the pancreas is overwhelmed by battling insulin resistance, diabetes develops. The strong association of increased fat, especially visceral fat, with diabetes makes this consequence particularly ominous for health care costs. The release of cytokines, particularly IL-6, from the fat cell may stimulate the proinflammatory state that characterizes obesity. The increased secretion of prothrombin activator inhibitor-1 from fat cells may play a role in the procoagulant state of obesity and, along with changes in endothelial function, may be responsible for the increased risk of cardiovascular disease and hypertension. For cancer, the production of estrogens by the enlarged stromal mass plays a role in the risk for breast cancer. Increased cytokine release may play a role in other forms of proliferative growth. The combined effect of these pathogenetic consequences of increased fat stores is an increased risk of shortened life expectancy.

Entities:  

Mesh:

Year:  2004        PMID: 15181027     DOI: 10.1210/jc.2004-0535

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  405 in total

1.  Pharmacokinetics and pharmacodynamics of MK-5046, a bombesin receptor subtype-3 (BRS-3) agonist, in healthy patients.

Authors:  Marc L Reitman; Victor Dishy; Allison Moreau; William S Denney; Chengcheng Liu; Walter K Kraft; Alex V Mejia; Mark A Matson; S Aubrey Stoch; John A Wagner; Eseng Lai
Journal:  J Clin Pharmacol       Date:  2011-12-12       Impact factor: 3.126

Review 2.  Calorie restriction: what recent results suggest for the future of ageing research.

Authors:  Daniel L Smith; Tim R Nagy; David B Allison
Journal:  Eur J Clin Invest       Date:  2010-05       Impact factor: 4.686

3.  Television viewing practices and obesity among women veterans.

Authors:  Kay M Johnson; Karin M Nelson; Katharine A Bradley
Journal:  J Gen Intern Med       Date:  2006-03       Impact factor: 5.128

4.  Obesity: maintenance of weight loss: setting our goals higher.

Authors:  George A Bray
Journal:  Nat Rev Endocrinol       Date:  2010-12       Impact factor: 43.330

5.  Weight loss: a tool to reduce proteinuria.

Authors:  Zohreh Soltani; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2011-04       Impact factor: 5.369

6.  A comparative study of five centrally acting drugs on the pharmacological treatment of obesity.

Authors:  H Suplicy; C L Boguszewski; C M C dos Santos; M do Desterro de Figueiredo; D R Cunha; R Radominski
Journal:  Int J Obes (Lond)       Date:  2013-11-29       Impact factor: 5.095

7.  Obesity and immune cell counts in women.

Authors:  Julie Womack; Phyllis C Tien; Joseph Feldman; Ja Hyun Shin; Kristopher Fennie; Kathryn Anastos; Mardge H Cohen; Melanie C Bacon; Howard Minkoff
Journal:  Metabolism       Date:  2007-07       Impact factor: 8.694

8.  Low grip strength predicts incident diabetes among mid-life women: the Michigan Study of Women's Health Across the Nation.

Authors:  Carrie A Karvonen-Gutierrez; Qing Peng; Mark Peterson; Kate Duchowny; Bin Nan; Sioban Harlow
Journal:  Age Ageing       Date:  2018-09-01       Impact factor: 10.668

9.  Change in levels of C-reactive protein (CRP) and serum cortisol in morbidly obese patients after laparoscopic sleeve gastrectomy.

Authors:  Jaime Ruiz-Tovar; Inmaculada Oller; Isabel Galindo; Carolina Llavero; Antonio Arroyo; Alicia Calero; María Diez; Lorea Zubiaga; Rafael Calpena
Journal:  Obes Surg       Date:  2013-06       Impact factor: 4.129

10.  Subclinical hypothyroidism, weight change, and body composition in the elderly: the Cardiovascular Health Study.

Authors:  Margaret C Garin; Alice M Arnold; Jennifer S Lee; Russell P Tracy; Anne R Cappola
Journal:  J Clin Endocrinol Metab       Date:  2014-01-16       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.